CD8A and melanoma: Even more intriguing were recent discoveries that TNF produced in an inflammatory response by transfused engineered CD8+ cells in adoptive cell therapy (ACT), induces dedifferentiation and survival of CD271+ melanoma cells with concomitant downregulation of targeted markers, resulting in relapse and eventual disease progression18,19.